ATE234093T1 - Cyano-indolen als serotoninwiederaufnahme inhibitoren und als 5-ht2c rezeptor liganden - Google Patents
Cyano-indolen als serotoninwiederaufnahme inhibitoren und als 5-ht2c rezeptor ligandenInfo
- Publication number
- ATE234093T1 ATE234093T1 AT00400193T AT00400193T ATE234093T1 AT E234093 T1 ATE234093 T1 AT E234093T1 AT 00400193 T AT00400193 T AT 00400193T AT 00400193 T AT00400193 T AT 00400193T AT E234093 T1 ATE234093 T1 AT E234093T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- cycloalkyl
- indolene
- cyano
- receptor ligands
- Prior art date
Links
- 102000006902 5-HT2C Serotonin Receptor Human genes 0.000 title 1
- 108010072553 5-HT2C Serotonin Receptor Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 10
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 5
- 125000001072 heteroaryl group Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- CBTITARLOCZPDU-UHFFFAOYSA-N 1h-indole-2-carbonitrile Chemical class C1=CC=C2NC(C#N)=CC2=C1 CBTITARLOCZPDU-UHFFFAOYSA-N 0.000 abstract 2
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004419 alkynylene group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9900801A FR2788772B1 (fr) | 1999-01-26 | 1999-01-26 | Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE234093T1 true ATE234093T1 (de) | 2003-03-15 |
Family
ID=9541208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00400193T ATE234093T1 (de) | 1999-01-26 | 2000-01-26 | Cyano-indolen als serotoninwiederaufnahme inhibitoren und als 5-ht2c rezeptor liganden |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6239129B1 (de) |
| EP (1) | EP1023898B1 (de) |
| JP (1) | JP2000212162A (de) |
| KR (1) | KR100445389B1 (de) |
| CN (1) | CN1155570C (de) |
| AT (1) | ATE234093T1 (de) |
| AU (1) | AU761084B2 (de) |
| BR (1) | BR0000158A (de) |
| CA (1) | CA2297279C (de) |
| DE (1) | DE60001591T2 (de) |
| DK (1) | DK1023898T3 (de) |
| EA (1) | EA003146B1 (de) |
| ES (1) | ES2193923T3 (de) |
| FR (1) | FR2788772B1 (de) |
| HU (1) | HUP0000308A2 (de) |
| MX (1) | MXPA00000856A (de) |
| NO (1) | NO314801B1 (de) |
| NZ (1) | NZ502494A (de) |
| PL (1) | PL338027A1 (de) |
| SI (1) | SI1023898T1 (de) |
| ZA (1) | ZA200000336B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001247562A (ja) * | 2000-03-07 | 2001-09-11 | Daicel Chem Ind Ltd | アミド化合物及びその製造方法 |
| SE0004245D0 (sv) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
| AU2426602A (en) * | 2000-11-20 | 2002-05-27 | Biovitrum Ab | Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor |
| CZ20032644A3 (en) | 2001-03-29 | 2004-06-16 | Bristol-Myers Squibb Company | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| CN1314669C (zh) * | 2002-09-17 | 2007-05-09 | 弗·哈夫曼-拉罗切有限公司 | 2,7－取代的吲哚以及它们作为5－ht6调节剂的用途 |
| US7129264B2 (en) * | 2003-04-16 | 2006-10-31 | Bristol-Myers Squibb Company | Biarylmethyl indolines and indoles as antithromboembolic agents |
| WO2005056522A2 (en) * | 2003-12-04 | 2005-06-23 | National Health Research Institutes | Indole compounds |
| FR2884251B1 (fr) * | 2005-04-08 | 2007-07-13 | Servier Lab | Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK181190D0 (da) * | 1990-07-30 | 1990-07-30 | Lundbeck & Co As H | 3-aryl-indol- eller 3-aryl-indazolderivater |
| TW270114B (de) * | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
| DE19500689A1 (de) * | 1995-01-12 | 1996-07-18 | Merck Patent Gmbh | Indolpiperidin-Derivate |
| US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| AU5343298A (en) * | 1997-01-13 | 1998-08-03 | Yamanouchi Pharmaceutical Co., Ltd. | 5-ht2c receptor agonists and aminoalkylindazole derivatives |
-
1999
- 1999-01-26 FR FR9900801A patent/FR2788772B1/fr not_active Expired - Fee Related
-
2000
- 2000-01-24 JP JP14544A patent/JP2000212162A/ja active Pending
- 2000-01-24 CA CA002297279A patent/CA2297279C/fr not_active Expired - Fee Related
- 2000-01-25 KR KR10-2000-0003388A patent/KR100445389B1/ko not_active Expired - Fee Related
- 2000-01-25 MX MXPA00000856A patent/MXPA00000856A/es not_active IP Right Cessation
- 2000-01-25 AU AU13553/00A patent/AU761084B2/en not_active Ceased
- 2000-01-25 US US09/490,909 patent/US6239129B1/en not_active Expired - Fee Related
- 2000-01-25 PL PL00338027A patent/PL338027A1/xx not_active Application Discontinuation
- 2000-01-25 NO NO20000373A patent/NO314801B1/no unknown
- 2000-01-25 EA EA200000068A patent/EA003146B1/ru not_active IP Right Cessation
- 2000-01-25 NZ NZ502494A patent/NZ502494A/en unknown
- 2000-01-25 BR BR0000158-9A patent/BR0000158A/pt not_active IP Right Cessation
- 2000-01-26 DK DK00400193T patent/DK1023898T3/da active
- 2000-01-26 HU HU0000308A patent/HUP0000308A2/hu unknown
- 2000-01-26 CN CNB001011561A patent/CN1155570C/zh not_active Expired - Fee Related
- 2000-01-26 ZA ZA200000336A patent/ZA200000336B/xx unknown
- 2000-01-26 EP EP00400193A patent/EP1023898B1/de not_active Expired - Lifetime
- 2000-01-26 DE DE60001591T patent/DE60001591T2/de not_active Expired - Fee Related
- 2000-01-26 ES ES00400193T patent/ES2193923T3/es not_active Expired - Lifetime
- 2000-01-26 SI SI200030063T patent/SI1023898T1/xx unknown
- 2000-01-26 AT AT00400193T patent/ATE234093T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL338027A1 (en) | 2000-07-31 |
| CA2297279A1 (fr) | 2000-07-26 |
| EA200000068A3 (ru) | 2000-10-30 |
| HK1029584A1 (en) | 2001-04-06 |
| AU1355300A (en) | 2000-07-27 |
| ZA200000336B (en) | 2000-08-15 |
| FR2788772A1 (fr) | 2000-07-28 |
| DE60001591T2 (de) | 2003-12-24 |
| HU0000308D0 (en) | 2000-03-28 |
| EA003146B1 (ru) | 2003-02-27 |
| HUP0000308A2 (en) | 2002-06-29 |
| NZ502494A (en) | 2001-06-29 |
| NO20000373D0 (no) | 2000-01-25 |
| US6239129B1 (en) | 2001-05-29 |
| NO20000373L (no) | 2000-07-27 |
| NO314801B1 (no) | 2003-05-26 |
| DE60001591D1 (de) | 2003-04-17 |
| MXPA00000856A (es) | 2002-03-08 |
| FR2788772B1 (fr) | 2001-03-02 |
| AU761084B2 (en) | 2003-05-29 |
| SI1023898T1 (en) | 2003-06-30 |
| CA2297279C (fr) | 2004-05-18 |
| EP1023898B1 (de) | 2003-03-12 |
| EA200000068A2 (ru) | 2000-08-28 |
| CN1266057A (zh) | 2000-09-13 |
| KR100445389B1 (ko) | 2004-08-25 |
| CN1155570C (zh) | 2004-06-30 |
| EP1023898A1 (de) | 2000-08-02 |
| DK1023898T3 (da) | 2003-06-10 |
| BR0000158A (pt) | 2000-09-19 |
| ES2193923T3 (es) | 2003-11-16 |
| KR20010006587A (ko) | 2001-01-26 |
| JP2000212162A (ja) | 2000-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP055644A (es) | Derivados de la quinolil-propil-piperidina y su utilización | |
| NO20022314D0 (no) | Stabile forbindelser av nye derivater av 3,3- difenylpropylaminer | |
| EA200601235A1 (ru) | Производные тиазола | |
| TNSN05069A1 (fr) | Derives de la quinolyl propyl piperidine et leur utilisation en tant qu'agents antimicrobiens | |
| AU9079198A (en) | Indolecarboxylic compounds and their use as pharmaceutical compounds | |
| ATE268767T1 (de) | N-aryl-piperidinderivate und ihre verwendung als 5-ht1b-rezeptorliganden | |
| DE60001591D1 (de) | Cyano-indolen als Serotoninwiederaufnahme Inhibitoren und als 5-HT2c Rezeptor Liganden | |
| MY125295A (en) | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives | |
| YU40998A (sh) | Derivati supstituisanog 1,2,3,4-tetrahidronaftalina | |
| ECSP930953A (es) | Nuevos derivados de indol | |
| ATE125808T1 (de) | Indolederivate und ihre verwendung als serotonin- antagoniste. | |
| RU2368608C2 (ru) | Производные пиперидина в качестве модуляторов хемокинового рецептора ccr5 | |
| ATE249457T1 (de) | Indolderivate und ihre verwendung als serotoninrezeptor-liganden | |
| ATE361283T1 (de) | Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten | |
| HRP20000508B1 (hr) | Supstituirani 2-benzilamino-2-fenil-acetamidni spojevi | |
| BR0208823A (pt) | Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica | |
| DK1161424T3 (da) | Hidtil ukendte diazolderivater som serotonerge midler | |
| DE69229845D1 (de) | 2-Piperazinylbenzimidazolderivate | |
| NO20002315L (no) | Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| NO955071D0 (no) | abeo-Ergolin-derivater som 5HT1A-ligander | |
| DK1140919T3 (da) | 1,4-Disubstituerede cyclohexanderivater til behandling af depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1023898 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |